Denali Therapeutics Inc.
NASDAQ:DNLIBiotechnology
Healthcare
$18.20 +0.40%
+$0.09 today
- Market cap
- $2.92B
- Beta
- 1.01
- P/E (TTM)
- -8.7
- EPS (TTM)
- -$2.72
52W Low $12.58High $24.65
Volume 1.27M
Average 1.84M
Price history
Denali Therapeutics Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+6.06%
Period high
$27.21
Period low
$16.02
Latest
$18.20
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 8-K | Nov 3, 2026 | Nov 3, 2026 | |
| 10-Q | Nov 3, 2026 | Nov 3, 2026 | |
| 4 | Sep 9, 2026 | Sep 9, 2026 | |
| 4 | Sep 4, 2026 | Sep 4, 2026 | |
| 4 | Sep 3, 2026 | Sep 3, 2026 | |
| 4 | Aug 14, 2026 | Aug 14, 2026 | |
| 4 | Aug 13, 2026 | Aug 13, 2026 | |
| 8-K | Aug 6, 2026 | Aug 6, 2026 | |
| 10-Q | Aug 6, 2026 | Aug 6, 2026 | |
| SC 13G/A | Aug 4, 2026 | Aug 4, 2026 | |
| 8-K | Jul 28, 2026 | Jul 27, 2026 | |
| SC 13G/A | Jul 8, 2026 | Jul 8, 2026 | |
| 8-K | Jun 18, 2026 | Jun 18, 2026 | |
| 4 | Jun 5, 2026 | Jun 5, 2026 | |
| 4 | Jun 5, 2026 | Jun 5, 2026 |
Competitors
Who does Denali Therapeutics Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about DNLI's filings, answered from its disclosures.
What is the latest DNLI filing?
The latest filing shown is 8-K dated Nov 3, 2026.
How many recent filings does DNLI have?
Intrinsic Alpha currently shows 20 recent filings for DNLI.
Continue the stock analysis
Jump to another research area for this company.